Marco Cavaco

14PUBLICATIONS
36CO-AUTHORS
Molecular targetsGlycoconjugatesGene and molecular therapyPredictive and prognostic markersInfectious agents
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 18, 2026
Multivalent peptides for blood-brain barrier translocation, cell penetration and microRNA-21 inhibition in glioblastoma.

|Aug 27, 2026
Linker Design in Antibody-Drug Conjugates: Balancing Stability and Drug Release.

|Jun 17, 2026
Chimeric peptide-based radiopharmaceuticals for glioblastoma imaging and therapy by targeting mHsp70 and enhancing BBB penetration.

|Jun 19, 2025
Antimigratory and Antiproliferative Effects of the Brain-Targeted Peptide Conjugate PepH3-vCPP2319 on Triple Negative Breast Cancer Cell Cultures.

Catarina Gonçalves, Miguel A R B Castanho, Marco Cavaco

|Apr 17, 2025
The Potential of Peptide-Based Inhibitors in Disrupting Protein-Protein Interactions for Targeted Cancer Therapy.

Alexandra L Afonso, Catarina T Cavaleiro, Miguel A R B Castanho

|Sep 05, 2023
Quantitative Imaging of the Action of vCPP2319, an Antimicrobial Peptide from a Viral Scaffold, against Staphylococcus aureus Biofilms of a Clinical Isolate.

Susana A Dias, Sandra N Pinto, Ana S Silva-Herdade

Pageof 3

Frequent Collaborators

13 joint publications

Miguel A R Castanho

10 joint publications

Vera Neves

7 joint publications

David Andreu

3 joint publications

Sira Defaus